• Medientyp: E-Artikel
  • Titel: Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020
  • Beteiligte: Towse, Adrian; Garau, Martina; Mohr, Penny; Messner, Donna A
  • Erschienen: Becaris Publishing Limited, 2015
  • Erschienen in: Journal of Comparative Effectiveness Research, 4 (2015) 4, Seite 401-418
  • Sprache: Englisch
  • DOI: 10.2217/cer.15.7
  • ISSN: 2042-6305; 2042-6313
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Aim: Explore key factors influencing future expectations for the production of evidence of relative effectiveness (RE) for drugs in Europe in 2020; construct three plausible future scenarios for RE evidence generation. Materials & methods: Semi-structured key informant interviews and three rounds of modified Delphi to gather expert perspectives and develop future scenarios. Results & conclusion: Most influential factors were degree of regulator use of postmarketing authorization (postlaunch) efficacy studies and adaptive licensing; degree of pan-European health technology assessment body coordination in reviewing prelaunch evidence and demanding postlaunch studies; the nature of regulator – health technology assessment body interaction. The most likely scenario entailed some change with postlaunch regulatory studies driving the likely nature of RE evidence generated.
  • Zugangsstatus: Freier Zugang